Aditxt (ADTX) Depreciation & Amortization (CF) (2020 - 2026)
Aditxt (ADTX) recorded quarterly Depreciation & Amortization (CF) of $47882.0 in Q1 2026, down 28.33% quarter-over-quarter from $66807.0 in Q4 2025, and down 30.05% on a YoY basis from $68450.0 in Q1 2025.
Aditxt (ADTX) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Aditxt's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $47882.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 30.05% year-over-year to $47882.0; the TTM figure through Mar 2026 stood at $248434.0 (down 53.95% YoY), while the FY2025 annual figure was $269271.0, down 56.14% from the prior year.
- Depreciation & Amortization (CF) was $47882.0 for Q1 2026 at Aditxt, down from $66807.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $165535.0 in Q4 2024 to a low of $47882.0 in Q1 2026.
- Historically, Depreciation & Amortization (CF) has averaged $105576.9 across 5 years, with a median of $105616.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Depreciation & Amortization (CF) jumped 56.73% in 2024, then sank 59.64% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $132292.0 in 2022, then decreased by 20.16% to $105616.0 in 2023, then jumped by 56.73% to $165535.0 in 2024, then tumbled by 59.64% to $66807.0 in 2025, then dropped by 28.33% to $47882.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $47882.0 (Q1 2026), $66807.0 (Q4 2025), and $66698.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | 47,882.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47,882.00 |
| Mar 31, 2026 | 47,882.00 |
| Dec 31, 2025 | 66,807.00 |
| Dec 31, 2025 | 66,807.00 |
| Sep 30, 2025 | 66,698.00 |
| Sep 30, 2025 | 66,698.00 |
| Jun 30, 2025 | 67,047.00 |
| Jun 30, 2025 | 67,047.00 |
| Mar 31, 2025 | 68,450.00 |
| Mar 31, 2025 | 68,450.00 |
| Dec 31, 2024 | 165,535.00 |
| Dec 31, 2024 | 165,535.00 |
| Sep 30, 2024 | 148,256.00 |
| Sep 30, 2024 | 148,256.00 |
| Jun 30, 2024 | 157,197.00 |
| Jun 30, 2024 | 157,197.00 |
| Mar 31, 2024 | 142,932.00 |
| Mar 31, 2024 | 142,932.00 |
| Dec 31, 2023 | 105,616.00 |
| Dec 31, 2023 | 105,616.00 |